Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8f82c4cf9e6f2349-LAX IP: 116.62.10.13 UTC time: 2024-12-26T17:25:12+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4